Recherches translationnelles sur le VIH et les maladies infectieuses, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale, Université de Montpellier, Montpellier, France; Centre de Recherche et de Formation en Infectiologie de Guinée, Université Gamal Abdel Nasser de Conakry, Conakry, Guinea.
Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France; Université de Lyon, Lyon, France; Université Lyon 1, Villeurbanne, France; Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique Santé, Pierre-Bénite, France.
Lancet Infect Dis. 2019 Mar;19(3):308-316. doi: 10.1016/S1473-3099(18)30649-2. Epub 2019 Feb 11.
The prevalence of Ebola virus infection among people who have been in contact with patients with Ebola virus disease remains unclear, but is essential to understand the dynamics of transmission. This study aimed to identify risk factors for seropositivity and to estimate the prevalence of Ebola virus infection in unvaccinated contact persons.
In this retrospective, cross-sectional observational study, we recruited individuals between May 12, 2016, and Sept 8, 2017, who had been in physical contact with a patient with Ebola virus disease, from four medical centres in Guinea (Conakry, Macenta, N'zérékoré, and Forécariah). Contact persons had to be 7 years or older and not diagnosed with Ebola virus disease. Participants were selected through the Postebogui survivors' cohort. We collected self-reported information on exposure and occurrence of symptoms after exposure using a questionnaire, and tested antibody response against glycoprotein, nucleoprotein, and 40-kDa viral protein of Zaire Ebola virus by taking a blood sample. The prevalence of Ebola virus infection was estimated with a latent class model.
1721 contact persons were interviewed and given blood tests, 331 of whom reported a history of vaccination so were excluded, resulting in a study population of 1390. Symptoms were reported by 216 (16%) contact persons. The median age of participants was 26 years (range 7-88) and 682 (49%) were male. Seropositivity was identified in 18 (8·33%, 95% CI 5·01-12·80) of 216 paucisymptomatic contact persons and 39 (3·32%, 5·01-12·80) of 1174 (2-4) asymptomatic individuals (p=0·0021). Seropositivity increased with participation in burial rituals (adjusted odds ratio [aOR] 2·30, 95% CI 1·21-4·17; p=0·0079) and exposure to blood or vomit (aOR 2·15, 1·23-3·91; p=0·0090). Frequency of Ebola virus infection varied from 3·06% (95% CI 1·84-5·05) in asymptomatic contact persons who did not participate in burial rituals to 5·98% (2·81-8·18) in those who did, and from 7·17% (3·94-9·09) in paucisymptomatic contact persons who did not participate in burial rituals to 17·16% (12·42-22·31) among those who did.
This study provides a new assessment of the prevalence of Ebola virus infection among contact persons according to exposure, provides evidence for the occurrence of paucisymptomatic cases, and reinforces the importance of closely monitoring at-risk contact persons.
Institut National de la Santé et de la Recherche Médicale, Reacting, the French Ebola Task Force, Institut de Recherche pour le Développement, and Montpellier University Of Excellence-University of Montpellier.
与埃博拉病毒病患者有过接触的人群中埃博拉病毒感染的流行情况尚不清楚,但了解传播动态至关重要。本研究旨在确定血清阳性的危险因素,并估计未接种疫苗的接触者中埃博拉病毒感染的患病率。
在这项回顾性、横断面观察性研究中,我们招募了 2016 年 5 月 12 日至 2017 年 9 月 8 日期间在几内亚(科纳克里、马森塔、恩泽雷科雷和福雷卡里亚)四家医疗中心与埃博拉病毒病患者有过身体接触的个体。接触者必须年满 7 岁,且未被诊断为埃博拉病毒病。通过 Postebogui 幸存者队列选择参与者。我们通过问卷调查收集接触后出现症状的暴露和发生情况的自我报告信息,并采集血样检测针对扎伊尔埃博拉病毒糖蛋白、核蛋白和 40kDa 病毒蛋白的抗体反应。使用潜在类别模型估计埃博拉病毒感染的患病率。
对 1721 名接触者进行了访谈和血液检测,其中 331 名接触者报告有疫苗接种史,因此被排除在外,最终纳入了 1390 名研究对象。216 名(16%)接触者报告有症状。参与者的中位年龄为 26 岁(范围 7-88),682 名(49%)为男性。216 名症状轻微的接触者中有 18 人(8.33%,95%CI5.01-12.80)和 1174 名(2-4)无症状个体中的 39 人(3.32%,5.01-12.80)血清阳性(p=0.0021)。参与丧葬仪式(调整后的优势比[aOR]2.30,95%CI1.21-4.17;p=0.0079)和接触血液或呕吐物(aOR2.15,1.23-3.91;p=0.0090)与血清阳性相关。无症状接触者中,未参与丧葬仪式者的埃博拉病毒感染率从 3.06%(95%CI1.84-5.05)到参与丧葬仪式者的 5.98%(2.81-8.18)不等,症状轻微接触者中,未参与丧葬仪式者的感染率从 7.17%(3.94-9.09)到参与丧葬仪式者的 17.16%(12.42-22.31)不等。
本研究根据接触情况对接触者中埃博拉病毒感染的流行情况进行了新的评估,为出现症状轻微病例提供了证据,并强调了密切监测高危接触者的重要性。
法国国立卫生与医学研究所、Reacting、法国埃博拉特别工作组、发展研究研究所和蒙彼利埃卓越大学-蒙彼利埃大学。